David Hughes and his team at Novartis (NYSE:NVS) have screened nearly a million compounds to find a few to specifically target the drug-resistant plasmodium parasite that causes malaria. This technique – of throwing hundreds of thousands of drugs through a variety of high-throughput tests and hoping to find the ones that perform well – is common […]
Boehringer Ingelheim’s Jardiance cuts risk of cardiovascular death in T2D patients
Boehringer Ingelheim and Eli Lilly (NYSE:LLY) touted post-hoc analyses today showing that Jardiance reduced the risk of cardiovascular death in people with Type II diabetes and established cardiovascular disease, independent of blood sugar control at the start of the study. The companies also reported a reduced risk in cardiovascular death when Jardiance was added to first […]
Ascensia Diabetes Care partners for mobile insulin management app
Ascensia Diabetes Care and Quattro Folia said today that the companies are partnering to combine Ascensia’s Contour Next One blood glucose monitoring system and Quattro Folia’s Balansio mobile insulin management app. According to the deal, the Contour Next One meter will connect via Bluetooth to the Balansio mobile app and deliver blood glucose readings to […]
Study: Sanofi’s diabetes drug brings earlier blood sugar control than insulin glargine
A post-hoc analysis of two late-stage trials of Sanofi‘s (NYSE:SNY) Soliqua insulin glargine and lixisenatide injection showed that it provides blood sugar control earlier and in more adults than just insulin glargine, the company reported. The analysis was presented today at the European Association for the Study of Diabetes in Portugal. Researchers reviewed data from […]
Study: Children with asthma more likely to be prescribed unnecessary antibiotics
Kids with asthma are more likely to be prescribed antibiotics, despite the fact that they don’t need them more than kids without asthma, according to a study that is slated to be presented at the European Respiratory Society International Congress. Researchers from Erasmus University in the Netherlands pointed out that it’s possible that asthma symptoms […]
Theraclion PI details breast cancer immunotherapy, ultrasound combo
The co-lead investigator for a metastatic breast cancer trial combining Theraclion‘s focused ultrasound technology and immunotherapy discussed the design and rationale of the study, the France-based company reported today. Dr. David Brenin, chief of breast surgery at the University of Virginia School of Medicine, said that although immuno-oncology has been gaining steam as a way to […]
Intersect ENT touts meta-analysis of steroid-releasing sinus implant
Intersect ENT (NSDQ:XENT) touted data today from a meta-analysis of two studies assessing the safety and efficacy of its investigational steroid-releasing sinus implant, Sinuva. The studies evaluated Sinuva in patients with recurrent and medically refractory nasal polyps. The meta-analysis, which was presented at the American Rhinologic Society’s annual meeting, included data from the Resolve and Resolve […]
Allergan alleges Imprimis makes, sells and promotes unapproved drugs – and Imprimis fires back
Last week, Allergan (NYSE:AGN) said that it filed lawsuits against Imprimis Pharmaceuticals (NSDQ:IMMY), Prescriber’s Choice and Sincerus Florida, claiming that the companies manufacture, sell and promote unapproved new drugs. The pharmaceutical giant filed suit in the U.S. District Court for the Central District of California. Today, Imprimis fired back at Allergan, denying the allegations and saying that […]
Regeneron, Sanofi tout topline Ph3 data for injectable asthma drug
Sanofi (NYSE:SNY) and Regeneron (NSDQ:REGN) touted data today from the pivotal Phase III trial of dupilumab in a group of patients with uncontrolled, persistent asthma. The drug is already approved for adults with certain forms of eczema. The two companies said they plan to seek FDA approval of dupilumab in asthma by the end of the year. […]
Replicel prototypes its next-gen dermal injector
RepliCel Life Sciences (OTC:REPCF) said yesterday that it has developed prototypes of its RCI-02 motorized injection device designed with programmable depth and volume, as well as interchangeable needle head configurations. The injector was built to deliver an array of substances, including dermal fillers, drugs, cells or biologics intradermally, subcutaneously or intramuscularly. The company said it hopes […]